Thyroid Cancer Mutation Panel

Thyroid Cancer Mutation Panel

Test Code

90469
81445
90469
81445
Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection is not available in your area through Quest Mobile.

Clinical Significance

Thyroid Cancer Mutation Panel - The thyroid mutation panel assesses for all 8 of the most common mutations or rearrangements associated with thyroid neoplasia.

The BRAF codon 600 mutation, and RET/PTC1 and RET/PTC3 rearrangements are highly associated with papillary thyroid cancer, the PAX8-PPAR{gamma} with follicular carcinomas and RAS mutations (in either HRAS, KRAS and NRAS) usually with follicular neoplasms.

See test codes 90477 (BRAF), 90473 (RET/PTC), 90474 (PPAR/PAX8), and 90479 (RAS panel) for individual components.

A thyroid cytology diagnosis code with reflex to molecular, as appropriate, is also available.

Test Resources

None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.

Test Details

Includes

  • BRAF Mutation Analysis, Papillary Thyroid Cancer
  • RAS Mutation Analysis, Thyroid Cancer
  • RET/PTC Rearrangement, Thyroid Cancer
  • PAX8/PPAR[gamma] Translocation, Thyroid Cancer

Methodology

See individual tests

Assay Category

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

BRAF Mutation Analysis, Papillary Thyroid Cancer

BRAF Mutation Not detected

RAS Mutation Analysis, Thyroid Cancer

HRAS Mutation Not detected
KRAS Mutation Not detected
NRAS Mutation Not detected

RET/PTC Rearrangement, Thyroid Cancer
RETPTC1 Not detected
RETPTC3 Not detected

PAX8/PPAR[gamma] Translocation, Thyroid Cancer

PAX8/PPAR Not detected

LOINC® Codes, Performing Laboratory

BRAF Mutation Analysis, Papillary Thyroid Cancer
RAS Mutation Analysis, Thyroid Cancer
RET/PTC Rearrangement, Thyroid Cancer
PAX8/PPAR[gamma] Translocation, Thyroid Cancer

Methodology

See individual tests
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

BRAF Mutation Analysis, Papillary Thyroid Cancer
BRAF Mutation Not detected

RAS Mutation Analysis, Thyroid Cancer

HRAS Mutation Not detected
KRAS Mutation Not detected
NRAS Mutation Not detected

RET/PTC Rearrangement, Thyroid Cancer
RETPTC1 Not detected
RETPTC3 Not detected

PAX8/PPAR[gamma] Translocation, Thyroid Cancer

PAX8/PPAR Not detected

Preferred Specimen(s)

1 formalin-fixed, paraffin-embedded tissue block or needle washing

Collection Instructions

Do not reject. Needle washings in alcohol-based fixative (e.g. Cytolyt ®) or formalin-fixed, paraffin-embedded tissue block FNA or FFPE specimens are acceptable for the assay. All specimens must be accompanied with pathology report. All FFPE specimens will be examined by a pathologist for confirmation and adequacy. Macrodissection, if warranted, is performed in the lab.

Transport Container

Fixative, slides or paraffin embedded tissue block

Transport Temperature

Room temperature

Specimen Stability

  • FNA or FFPE
  • Room temperature: 5 years 
  • Refrigerated: 5 years
  • Frozen: Unacceptable
  •  
  • Needle washings
  • Room temperature: 30 days 
  • Refrigerated: 30 days
  • Frozen: Unacceptable

Reject Criteria

DO NOT REJECT

Setup Schedule

1 formalin-fixed, paraffin-embedded tissue block or needle washing

Do not reject. Needle washings in alcohol-based fixative (e.g. Cytolyt ®) or formalin-fixed, paraffin-embedded tissue block FNA or FFPE specimens are acceptable for the assay. All specimens must be accompanied with pathology report. All FFPE specimens will be examined by a pathologist for confirmation and adequacy. Macrodissection, if warranted, is performed in the lab.

Fixative, slides or paraffin embedded tissue block
Room temperature
FNA or FFPE
Room temperature: 5 years 
Refrigerated: 5 years
Frozen: Unacceptable

Needle washings
Room temperature: 30 days 
Refrigerated: 30 days
Frozen: Unacceptable

DO NOT REJECT

Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection is not available in your area through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.